Winhealth to Market Two Cumberland Pharma Pain Drugs in China
publication date: May 15, 2019
China's Winhealth Pharma has in-licensed greater China rights for two FDA approved pain management drugs from Cumberland Pharma. Winhealth will have rights to distribute Acetadote® (acetylcysteine) Injection, used to treat liver damage from acetaminophen overdose, and Caldolor® (ibuprofen) Injection, used to treat pain and fever in hospitals. Winhealth currently markets 12 pharmaceutical products in China via partnerships with multinational pharmas and other companies. Established in 2006, Winhealth was founded in Hangzhou and now has its headquarters in Hong Kong. More details....
Stock Symbol: (NSDQ: CPIX)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.